文档下载 文档下载导航
设为首页 | 加入收藏
搜索 请输入内容:  
 导航当前位置: 文档下载 > 所有分类 > 工程科技 > 电子/电路 > Serratiopeptidase A systematic review of the existing evidence
侵权投诉

Serratiopeptidase A systematic review of the existing evidence

Nakamura et al. 2003

Chronic airway disease 20

29 patient (15 in treatment and 14 in non-treatment group)

Randomized, open label trial with

non-treatment control group

Serratiopeptidase 30 mg/day

No treatment

4 weeks

TSP treatment decreased sputum weight,% solid component, viscosity and elasticity, sputum neutrophil count, and other symptoms TSP increased transfer of sulbenicilin into exudates TSP group showed improvement in rhinorrhoea, nasal stuf ness, coryza and paranasal sinus shadow TSP group had signi cant higher level of antibiotic in tissues

1À

Grading of evidence for its role in increasing antimicrobial ef cacy Osteoarticular 8 patient Okumura infection et al. 1977 21 Brewer science library 199922 Perennial rhinitis, chronic rhinitis with sinusitis, chronic bronchitis Lung cancer patients undergoing thoracotomy 93 patient

Prospective, open label Randomized, double blind

Serratiopeptidase 30 mg/dayþ sulbenicillin Serratiopeptidaseþ Cephalexin

Sulbenicillin alone Placeboþ Cephalexin

6 days

2À

e

1À

Koyama et al. 198623

35 patient (18 in serratioþ cefotiam and 17 in cefotiam alone group)

Randomized, open label

Serratiopeptidase (20 mg three times per day)þ Cefotiam 2 g Serratiopeptidase 5 mgþ Paracetamol 1000 mg

Cefotiam 2 g single dose

Prophylaxis before surgery (days not mentioned) 7 days

1À

Grading of evidence for use of serratiopeptidase in dentistry Surgical removal of 24 Khateeb symmetrically et al. 2008 24 impacted mandibular third molars Chopra D et al. 200925 Postoperative sequel following removal of impacted 3rd molar 150 patient divided randomly into 5 groups

S. Bhagat et al./ International Journal of Surgery 11 (2013) 209e217

Prospective, intraindividual, randomized, doubleblind, Cross-over study Randomized, doubleblind, placebo-controlled trial

Placeboþ paracetamol 1000 mg

Serratiopeptidase (20 mg thrice daily)

Ibuprofen 600 mg or betamethasone 0.5 mg or paracetamol 1 g or placebo each given thrice daily No medication

7 days

Surachai et al. 26

Postoperative swelling after removal of impacted molars

40 (20 per group)

Not stated

Serratiopeptidase (5 mg thrice daily)

5 days

TSP group showed signi cant reduction in extent of cheek swelling and pain intensity but no difference in mean maximal interincisal distance between 2 groups. TSP group showed less mean pain scores and swelling as compared to placebo but difference not statistically signi cant. Also TSP not superior when compared to ibuprofen and betamethasone No signi cant difference in degree of facial swelling and maximum mouth opening seen in two groups

1þ

1þ

REVIEW

2À

TSP: serratiopeptidase, and SAP: seaprose.

213

Serratiopeptidase A systematic review of the existing evidence

上一页第5页

你可能喜欢

热门文档

相关文档

站点地图 | 文档上传 | 侵权投诉 | 手机版
本站所有资源均来自互联网,本站只负责收集和整理,均不承担任何法律责任,如有侵权等其它行为请联系我们.
文档下载 Copyright 2013 doc.guandang.net All Rights Reserved.  -  email